MicroRNA signatures highlight new breast cancer subtypes

被引:33
作者
Bhattacharyya, Malay [1 ]
Nath, Joyshree [2 ]
Bandyopadhyay, Sanghamitra [2 ]
机构
[1] Indian Inst Engn Sci & Technol, Dept Informat Technol, Sibpur 711103, Howrah, India
[2] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, India
关键词
Breast cancer; MicroRNA; Cancer subtype; Survival analysis; EXPRESSION; TUMORS; RISK;
D O I
10.1016/j.gene.2014.11.053
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MicroRNAs (miRNAs) are a kind of short non-coding RNAs, of about 22 nucleotides in length, which modulate and sometimes degrade the target mRNAs thereby regulating a number of cellular functions. Recent research in this area establishes the involvement of miRNAs in various disease progressions, including certain types of cancer development Further, genome-wide expression profiling of miRNAs has been proven to be useful for differentiating various cancer types. In this paper, we have used miRNA expression profiles over a large set of breast cancer tumor samples for identifying subtypes of breast cancers. The experimental results demonstrate that miRNAs carry a unique signature that distinguishes cancer subtypes and reveal new cancer subtypes. Additional survival analyses based on clinical data also strengthen this claim. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [21] Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer
    Han, Yiqun
    Wang, Jiayu
    Xu, Binghe
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [22] Obesity, leptin, and deregulation of microRNA in lipid metabolisms: their contribution to breast cancer prognosis
    Taroeno-Hariadi, Kartika W.
    Hardianti, Mardiah S.
    Sinorita, Hemi
    Aryandono, Teguh
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)
  • [23] Diagnostic and Prognostic Potential of MiR-379/656 MicroRNA Cluster in Molecular Subtypes of Breast Cancer
    Lal, Megha
    Ansari, Asgar Hussain
    Agrawal, Anurag
    Mukhopadhyay, Arijit
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [24] Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes
    Sulaiman, Fatima
    Khyriem, Costerwell
    Dsouza, Stafny
    Abdul, Fatima
    Alkhnbashi, Omer
    Faraji, Hanan
    Farooqi, Muhammad
    Al Awadi, Fatheya
    Hassanein, Mohammed
    Ahmed, Fayha
    Alsharhan, Mouza
    Tawfik, Abdel Rahman
    Khamis, Amar Hassan
    Bayoumi, Riad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [25] Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study
    Bensen, Jeannette T.
    Tse, Chiu Kit
    Nyante, Sarah J.
    Barnholtz-Sloan, Jill S.
    Cole, Stephen R.
    Millikan, Robert C.
    CANCER CAUSES & CONTROL, 2013, 24 (06) : 1099 - 1109
  • [26] Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer
    Wei, Jingchao
    Yin, Yinghao
    Deng, Qiancheng
    Zhou, Jun
    Wang, Yong
    Yin, Guangming
    Yang, Jianfu
    Tang, Yuxin
    FRONTIERS IN GENETICS, 2020, 11
  • [27] Identifying significant microRNA-mRNA pairs associated with breast cancer subtypes
    Bhattacharyya, Malay
    Nath, Joyshree
    Bandyopadhyay, Sanghamitra
    MOLECULAR BIOLOGY REPORTS, 2016, 43 (07) : 591 - 599
  • [28] Potential roles of the exosome/microRNA axis in breast cancer
    Mamalo, Alireza Soleimani
    Alivirdiloo, Vahid
    Sadeghnejad, Azadeh
    Hajiabbasi, Mobasher
    Gargari, Morad Kohandel
    Valilo, Mohammad
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [29] Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer
    Norouzi, Saeed
    Majeed, Muhammed
    Pirro, Matteo
    Generali, Daniele
    Sahebkar, Amirhossein
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (02) : 171 - 177
  • [30] The Association Between Mammographic Density and Molecular Subtypes of Breast Cancer
    Kilic, Murat Ozgur
    Ucar, Ali Yalcin
    INDIAN JOURNAL OF SURGERY, 2020, 82 (02) : 191 - 196